Scholarlink

<p>The aim of this study was to evaluate the pharmacokinetics of eugenol in pacu (<i>Piaractus mesopotamicus</i>) juveniles following exposure to an immersion bath. Pacu juveniles (<i>n</i> = 42) with an average weight of 546.40 ± 74.51&#xa0;g and total length of 25.43 ± 1.52&#xa0;cm were subjected to a bath with 100 mg L<sup>−1</sup> eugenol previously dissolved in 95% ethanol (1:10). After a 10-min immersion, the fish were transferred to anesthetic-free aquaria for recovery. Blood, kidney, muscle, spleen, gills, and brain samples were collected at intervals 0, 0.5, 1.0, 3.0, 6.0, 12.0, and 24.0&#xa0;h post-anesthesia. Pharmacokinetic parameters were calculated using non-compartmental methods. The highest eugenol concentrations were recorded immediately after anesthesia (0&#xa0;h) in all tissues, in descending order: plasma &gt; kidney &gt; muscle &gt; spleen &gt; gills &gt; brain. The plasma and brain half-lives of eugenol were 1.12&#xa0;h and 0.73&#xa0;h, respectively, with elimination constants of 0.62 and 0.95 per hour. In muscle and kidney tissues, the half-lives were 0.14&#xa0;h and 0.09&#xa0;h, with elimination constants of 4.97 and 7.44 per hour, respectively. In the spleen and gills, the half-lives were 0.21&#xa0;h and 0.23&#xa0;h, with elimination constants of 3.26 and 3.07 per hour. In conclusion, eugenol is rapidly absorbed and eliminated in growing phase pacu, reaching peak concentrations soon after anesthesia and showing a significant reduction up to 24&#xa0;h.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Residual depletion of eugenol as an anesthetic in growing phase pacu (Piaractus mesopotamicus)

  • 期刊论文

  • 发表日期：

    2025年4月17日

查看全文
  • Caio Francisco Santana Farias,
  • Jayme Aparecido Povh,
  • Ruy Alberto Caetano Corrêa Filho,
  • Andrea Maria de Araújo Gabriel,
  • Claudia Andrea Lima Cardoso,
  • Adryadine Almeida da Costa,
  • Antônio Francisco Oliveira,
  • Gabriela Tomas Jerônimo,
  • Maurício Laterça Martins,
  • Arlene Sobrinho Ventura

摘要

The aim of this study was to evaluate the pharmacokinetics of eugenol in pacu (Piaractus mesopotamicus) juveniles following exposure to an immersion bath. Pacu juveniles (n = 42) with an average weight of 546.40 ± 74.51 g and total length of 25.43 ± 1.52 cm were subjected to a bath with 100 mg L−1 eugenol previously dissolved in 95% ethanol (1:10). After a 10-min immersion, the fish were transferred to anesthetic-free aquaria for recovery. Blood, kidney, muscle, spleen, gills, and brain samples were collected at intervals 0, 0.5, 1.0, 3.0, 6.0, 12.0, and 24.0 h post-anesthesia. Pharmacokinetic parameters were calculated using non-compartmental methods. The highest eugenol concentrations were recorded immediately after anesthesia (0 h) in all tissues, in descending order: plasma > kidney > muscle > spleen > gills > brain. The plasma and brain half-lives of eugenol were 1.12 h and 0.73 h, respectively, with elimination constants of 0.62 and 0.95 per hour. In muscle and kidney tissues, the half-lives were 0.14 h and 0.09 h, with elimination constants of 4.97 and 7.44 per hour, respectively. In the spleen and gills, the half-lives were 0.21 h and 0.23 h, with elimination constants of 3.26 and 3.07 per hour. In conclusion, eugenol is rapidly absorbed and eliminated in growing phase pacu, reaching peak concentrations soon after anesthesia and showing a significant reduction up to 24 h.